34,583 public posts
Want to take advantage of all our features? Just log in!
or
Your experiences of trametinib needed (online survey)
The National Cancer Medicines Advisory Group (NCMAG) Programme have approached Ovacome as they are currently considering trametinib for patients with recurrent or progressive low grade serous ovarian carcinoma after at least one line of platinum-based chemotherapy for off-label use in NHSScotland.